Literature DB >> 16854049

Aromatic interactions with phenylalanine 691 and cysteine 828: a concept for FMS-like tyrosine kinase-3 inhibition. Application to the discovery of a new class of potential antileukemia agents.

Pascal Furet1, Guido Bold, Thomas Meyer, Johannes Roesel, Vito Guagnano.   

Abstract

FLT3 kinase inhibitors are currently under investigation as a new treatment for acute myeloid leukemia. We report here a molecular concept invoking interactions between an aromatic ring and the side chains of Phe691 and Cys828, two residues of the ATP pocket, to obtain potent and specific inhibitors of this kinase. The hypothesis has been validated by the successful design of a new inhibitor prototype showing promising antiproliferative activity in cellular assays.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16854049     DOI: 10.1021/jm060368s

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  6 in total

1.  Managing bias in ROC curves.

Authors:  Robert D Clark; Daniel J Webster-Clark
Journal:  J Comput Aided Mol Des       Date:  2008-02-07       Impact factor: 3.686

2.  Pim kinases phosphorylate Chk1 and regulate its functions in acute myeloid leukemia.

Authors:  L L Yuan; A S Green; S Bertoli; F Grimal; V Mansat-De Mas; C Dozier; J Tamburini; C Récher; C Didier; S Manenti
Journal:  Leukemia       Date:  2013-06-10       Impact factor: 11.528

3.  Wnt/β-catenin Pathway Modulates the Sensitivity of the Mutant FLT3 Receptor Kinase Inhibitors in a GSK-3β Dependent Manner.

Authors:  Jingrui Jiang; James D Griffin
Journal:  Genes Cancer       Date:  2010-02

4.  Cellular protection using Flt3 and PI3Kα inhibitors demonstrates multiple mechanisms of oxidative glutamate toxicity.

Authors:  Yunyi Kang; Stefano Tiziani; Goonho Park; Marcus Kaul; Giovanni Paternostro
Journal:  Nat Commun       Date:  2014-04-17       Impact factor: 14.919

5.  CDC25A governs proliferation and differentiation of FLT3-ITD acute myeloid leukemia.

Authors:  Sarah Bertoli; Helena Boutzen; Laure David; Clément Larrue; François Vergez; Anne Fernandez-Vidal; Lingli Yuan; Marie-Anne Hospital; Jérôme Tamburini; Cécile Demur; Eric Delabesse; Estelle Saland; Jean-Emmanuel Sarry; Marie-Odile Galcera; Véronique Mansat-De Mas; Christine Didier; Christine Dozier; Christian Récher; Stéphane Manenti
Journal:  Oncotarget       Date:  2015-11-10

6.  Heat shock protein 70 inhibitors. 2. 2,5'-thiodipyrimidines, 5-(phenylthio)pyrimidines, 2-(pyridin-3-ylthio)pyrimidines, and 3-(phenylthio)pyridines as reversible binders to an allosteric site on heat shock protein 70.

Authors:  Tony Taldone; Yanlong Kang; Hardik J Patel; Maulik R Patel; Pallav D Patel; Anna Rodina; Yogita Patel; Alexander Gozman; Ronnie Maharaj; Cristina C Clement; Alvin Lu; Jason C Young; Gabriela Chiosis
Journal:  J Med Chem       Date:  2014-02-18       Impact factor: 7.446

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.